Frequency of antiphospholipid antibodies and antiphospholipid syndrome in women with recurrent miscarriages;Częstość występowania przeciwciał antyfosfolipidowych i zespołu antyfosfolipidowego u kobiet z poronieniami nawracającymi

Ginekologia Polska

Volumn 82, Issue 1, 2011, Pages 32-38

  Rajewski, Marcin ^a   Skrzypczak, Jana ^a  

^a Ginekologicznej Uniwersytetu Medycznego   (Poland)

Author keywords

Antiphospholipid antibodies (aPL); Antiphospholipid syndrome (APS); Early recurrent miscarriages; Late recurrent miscarriages

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD; COMORBIDITY; COMPARATIVE STUDY; FEMALE; HUMAN; PREGNANCY; RECURRENT ABORTION; RECURRENT DISEASE; RISK FACTOR; WOMEN'S HEALTH;

ABORTION, HABITUAL; ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; COMORBIDITY; FEMALE; HUMANS; PREGNANCY; RECURRENCE; RISK FACTORS; WOMEN'S HEALTH; YOUNG ADULT;

EID: 79551598524     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Zawilska K. Przeciwciała antyfosfolipidowe-czynnik zagrożenia żylna{ogonek} choroba{ogonek} zakrzepowozatorowa{ogonek} i zakrzepica{ogonek} te{ogonek}tnicza{ogonek}. Pol Arch Med Wew. 2007, suppl., 41-45.
2. Malinowski A, Wilczyński J. Immunophysiology of normal pregnancy. Part II. Immunoregulatory mechanisms of placental origin and systemic immunological response. Ginekol Pol. 2004, 75, 553-569. Polish.
3. Stone S, Khamashta M, Poston L. Placentation, antiphospholipid syndrome and pregnancy outcome. Lupus. 2001, 10, 67-74.
4. Ruffatti A, Tonello M, Del Ross T. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Haemost. 2006, 96, 337-341.
5. Nielsen H, Christiansen O. Prognostic impact of anticariolipin antibodies in women with recurrent miscarriage negative for the lupus anticoagulant. Hum Reprod. 2005, 20, 1720-1728.
6. Stern C, Baker H, Chamley L. Human reproductive failure is not a clinical feature associated with beta 2 glycoprotein-I antibodies in anticardiolipin and lupus anticoagulant seronegative patients. Hum Reprod. 2000, 15, 976-978.
7. Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol. 2006, 132, 171-196.
8. James A, Abel D, Brancazio L. Anticoagulants in Pregnancy. Obstet Gynecol Surv. 2006, 61, 59-69.
9. Lockshin M, Sammaritano L, Schwartzman S. Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum. 2000, 43, 440-443.
10. Miyakis S, Lockshin M, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006, 4, 295-306.
11. Farquharson R, Jauniaux E, Exalto N, et al. Updated and revised nomenclature for description of early pregnancy events. Hum Reprod. 2005, 20, 3008-3011.
12. Rai R, Regan L. Thrombophilia and Adverse Pregnancy Outcome. Semin Reprod Med. 2000, 18, 369-377.
13. Oshiro S, Motomura K, Fukushima T. Systemic lupus erythematosus manifesting as subarachnoid hemorrhage induced by cortical venous thrombosis and followed by medial medullary infarction. No To Shinkei. 2003, 55, 791-795. Japanese.
14. Dydowicz P. Korelacja wyste{ogonek}powania przeciwciał antyfosfolipidowych z wybranymi parametrami klinicznymi u kobiet z nawracaja{ogonek}cymi poronieniami. Rozprawa Doktorska. Poznań: uniwersytet Medyczny im. Karola Marcinkowskiego. 200.
15. Farquharson R, Quenby S, Greaves M. Antiphospholipid syndrome in Pregnancy: A Randomized, Controlled Trial of Treatment. Obstet Gynecol. 2002, 100, 408-413.
16. Galli M. Antiphospholipid antibodies and thrombosis: do test patterns identify the patients' risk?. Thromb Res. 2004, 114, 597-601.
17. Branch W. Antiphospholipid syndrome and thrombosis. Clin Obstet Gynecol. 2006, 49, 861-874.
18. Sailer T, Zoghlami C, Kurz Ch. Anti-beta2-glycoprotein I antibodies are associated with pregnancy loss in women with the lupus anticoagulant. Thromb Haemost. 2006, 95, 796-801.
19. Rodney D, Hollier N, Kutteh W. (2-Glycoprotein 1 as a marker of antiphospholipid syndrome in women with recurrent pregnancy loss. Fertil Steril. 2000, 3, 531-535.
20. Couto E, Barini R, Zaccaria R, et al. Assocation of anticardiolipin antibody and C 677T in MTHFR in women with recurrent spontaneus abortions: a new path to thrombophilia? Sao Paulo Med J. 2005,123, 15-20.
21. Rogue H, Paidas M, Funai E, et al. Maternal thrombophilias are not associated with early pregnancy loss. Thromb Haemost. 2004, 91, 290-295.
22. Mezzesimi A, Florio P, Reis F, et al. The detection of anti-beta2-glycoprotein I antibodies is associated with increased risk of pregnancy loss in women with threatened abortion in the first trimester. Eur J Obstet Gynecol Reprod Biol. 2007, 133, 164-168.
23. Zammiti W, Mtiraoui N, Hidar S, et al. Antibodies to beta2-glycoprotein and annexin V in women with early and late idiopathic recurrent spontaneus abortions. Arch Gynecol Obstet. 2006, 274, 261-265.
24. Aoki K, Dudkiewicz A, Matsuura E, et al. Clinical significance of beta 2-glycoprotein I-dependent anticardiolipin antibodies in the reproductive autoimmune failure syndrome: correlation with conventional antiphospholipid antibody detection system. Am J Obstet Gynecol. 1995, 172, 926-931.
25. Lee E, Lee C, Lee T, et al. Does the anti-beta2-glycoprotein I antibody provide additional information in patients with thrombosis? Thromb Res. 2003, 111, 29-32.
26. Lee R, Emlen W, Scott J, et al. Anti beta2-glycoprotein I antibodies in women with recurrent spontaneus abortion, unexplained fetal death, and antiphospholipid syndrome. Am J Obstet Gynecol. 1999, 181, 642-648.
27. Quenby S, Farquharson R, Dawood F, et al. Recurrent miscarriage and long-term thrombosis risk: a case-control study. Hum Reprod. 2005, 20, 1729-1732.
28. Rand J, WU X, Andree H, et al. Pregnancy loss in the antiphospholipid-antibody syndrome-a possible thrombogenetic mechanism. N Eng J Med. 1997, 337, 154-160.
29. Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol. 2002, 101, 6-14.
30. Coulam C, Jeyendran R, Fishel L, et al. Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage. Am J Reprod Immunol. 2006, 55, 360-368.
31. Farquharson R, Quenby S, Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol. 2002, 100, 408-413.
32. Stephenson M. Management of recurrent early pregnancy loss. J Reprod Med. 2006, 51, 303-310.
33. Goldmann J, Bettes B, Robinson J, et al. Thrombophilia and the Obstetric Patient. Obstet Gynecol. 2007, 110, 669-675.
34. Brenner B. Thrombophilia and Adverse Pregnancy Outcome. Obstet Gynecol Clin North Am. 2006, 2, 443-456.
35. American College of Obstetricians and Gynecologists. ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. (Replaces Technical Bulletin Number 212, September 1995). Int J Gynaecol Obstet. 2002, 78, 179-190.
36. Stone S, Langford K, Nelson-Piercy C, et al. Antiphospholipid antibodies do not a syndrome make. Lupus. 2002, 11, 130-133.
37. Kutteh W, Park V, Deticher R. Hypercoagulable state mutation analysis In white patients with Elary first-trimester recurrent pregnancy loss. Fertil Steril. 1999, 71, 1048-1053.